Overview
Consumer products firm's fiscal Q1 sales rose 1.9%, beating analyst expectations
Adjusted EPS for fiscal Q1 beat analyst expectations
Company completed $340 mln divestiture of Feminine Care business
Outlook
Edgewell expects fiscal 2026 net sales to increase 0.5% to 3.5%
Adjusted EPS forecast revised to $1.70-$2.10 for fiscal 2026
Adjusted EBITDA expected between $245 mln and $265 mln for fiscal 2026
Result Drivers
DIVESTITURE IMPACT - Completion of Feminine Care business divestiture expected to positively impact financial outlook, per CEO Rod Little
ORGANIC SALES DECLINE - Organic net sales decreased 0.5%, with North American growth offset by international declines, notably in Japan
GROSS MARGIN PRESSURE - Gross margin decreased due to core inflation, tariffs, and unfavorable mix, despite productivity savings
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q1 Sales | Beat | $486.80 mln | $477.68 mln (5 Analysts) |
Q1 Adjusted EPS | Beat | $0.03 | -$0.16 (7 Analysts) |
Q1 Adjusted EBITDA | Beat | $38.10 mln | $29.59 mln (4 Analysts) |
Q1 Adjusted Operating Income | Miss | $8.10 mln | $8.84 mln (5 Analysts) |
Q1 Gross Profit | $161 mln |
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the personal products peer group is "buy."
Wall Street's median 12-month price target for Edgewell Personal Care Co is $20.50, about 1.2% above its February 6 closing price of $20.75
The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 7 three months ago
Press Release: ID:nPn2NBdDHa
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)